cell therapy
Showing 9976 - 10000 of >10,000
Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage Trial in United States (radiation, drug,
Recruiting
- Acute Biphenotypic Leukemia
- +11 more
- Total-Body Irradiation
- +8 more
-
Los Angeles, California
- +9 more
Aug 19, 2022
Allergic Rhinitis, Rhinosinusitis Chronic Trial (Olfactory mucosa-derived mesenchymal stem cells, Standard treatment of type
Not yet recruiting
- Allergic Rhinitis
- Rhinosinusitis Chronic
- Olfactory mucosa-derived mesenchymal stem cells
- +2 more
- (no location specified)
Jan 18, 2022
NSCLC Stage IV, HIV, HBV Trial in Verona (Nivolumab and Ipilimumab)
Not yet recruiting
- NSCLC Stage IV
- +4 more
- Nivolumab and Ipilimumab
-
Verona, Veneto/Verona, ItalyCentro Ricerche Cliniche
Oct 26, 2022
Polymyalgia Rheumatica Trial (Secukinumab 300 mg, Secukinumab 150 mg, Placebo to secukinumab)
Not yet recruiting
- Polymyalgia Rheumatica
- Secukinumab 300 mg
- +2 more
- (no location specified)
Mar 6, 2023
Clear Cell Renal Cell Carcinoma, Solid Tumors Trial (AB521)
Not yet recruiting
- Clear Cell Renal Cell Carcinoma
- Solid Tumors
- (no location specified)
Sep 7, 2022
Hematologic Diseases, Bone Marrow Transplantation, Hematopoietic Stem Cell Transplantation Trial in Paris (NewSpringForMe
Recruiting
- Hematologic Diseases
- +2 more
- NewSpringForMe digital solution
-
Paris, FranceService Hématologie Greffe Trèfle 3, Hôpital Saint-Louis, AP-HP
Nov 22, 2023
Autologous Natural Killer Cell Activity in Primary Cancer Cell
Recruiting
- Sarcoma
-
Santa Monica, CaliforniaSarcoma Oncology Research Center
May 19, 2023
Sarcoma, Kaposi, HIV Trial in Los Angeles, Chicago (Interferon beta-1b, Zidovudine)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Interferon beta-1b
- Zidovudine
-
Los Angeles, California
- +3 more
Oct 26, 2021
Lymphoma, Diffuse Large B-cell Lymphoma Trial in Worldwide (Lenalidomide, Placebo)
Completed
- Lymphoma
- Diffuse Large B-cell Lymphoma
- Lenalidomide
- Placebo
-
Bendigo, Australia
- +156 more
Jul 23, 2021
Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemo, Platinum Sensitive Trial in China,
Active, not recruiting
- Relapsed Ovarian Cancer
- +2 more
- Olaparib 300mg tablets
-
Beijing, China
- +24 more
Dec 5, 2022
T-Cell Lymphoma Trial in Saint Louis (Duvelisib, Peripheral blood draw)
Recruiting
- T-Cell Lymphoma
- Duvelisib
- Peripheral blood draw
-
Saint Louis, MissouriWashington University School of Medicine
Jul 18, 2022
Advanced Solid Tumor Trial in Xiamen, Jinan, Linyi (FP002 Injection)
Recruiting
- Advanced Solid Tumor
- FP002 Injection
-
Xiamen, Fujian, China
- +2 more
Aug 9, 2023
DERM US and EU Validation Study
Active, not recruiting
- Malignant Skin Melanoma T0
- +2 more
- Deep Ensemble for the Recognition of Malignancy (DERM)
-
Redwood City, California
- +15 more
Aug 23, 2022
Mantle Cell Lymphoma Trial in Houston (Acalabrutinib)
Recruiting
- Mantle Cell Lymphoma
-
Houston, TexasM D Anderson Cancer Center
Aug 22, 2022
Breast Cancer, Supplementation, Resistance Training Trial (Creatine supplementation, Resistance training)
Not yet recruiting
- Breast Cancer
- +4 more
- Creatine supplementation
- Resistance training
- (no location specified)
May 26, 2023
Patients at Risk for Chronic Graft-Versus-Host Disease
Not yet recruiting
- cGVHD
- Non-Interventional
- (no location specified)
Jun 16, 2023
Postoperative Hypoparathyroidism Trial (Allogenic parathyroid cells, Standard treatment according to the Clinical protocols)
Not yet recruiting
- Postoperative Hypoparathyroidism
- Allogenic parathyroid cells
- Standard treatment according to the Clinical protocols
- (no location specified)
Jan 12, 2022
Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Platinum-Resistant Lung Small Cell Carcinoma
Recruiting
- Extensive Stage Lung Small Cell Carcinoma
- +3 more
- Biopsy
- +4 more
-
Los Angeles, California
- +8 more
Jan 31, 2023
AI Based Multi-modal Parameter of Peripheral Blood Cells
Recruiting
- Children
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Sep 12, 2023
B-ALL Trial in Hangzhou (ThisCART19A)
Recruiting
- B-ALL
- ThisCART19A
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Apr 26, 2022
DevelopingShared Decision Making Tool for Surgically Removed
Recruiting
- Lung Non-Small Cell Carcinoma
- Discussion
- Questionnaire Administration
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Lung Cancer, Metastatic Cancer Trial in Indianapolis (Treatment Planning using the DIBH Technique)
Recruiting
- Lung Cancer
- Metastatic Cancer
- Treatment Planning using the DIBH Technique
-
Indianapolis, IndianaIndiana University Hospital / IU Simon Cancer Center
Apr 12, 2022